[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06704867":3,"trial-entities:NCT06704867":48,"trial-summary:NCT06704867":48},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":24,"primary_purpose":25,"phases":26,"enrollment_info":28,"interventions":31,"primary_outcomes":36,"secondary_outcomes":41,"sex":46,"minimum_age":47,"maximum_age":48,"healthy_volunteers":15,"eligibility_criteria":49,"std_ages":63,"locations":66,"central_contacts":75,"overall_officials":76,"references":80,"see_also_links":81},"NCT06704867","24-003924","High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound","High Flow Nasal Cannula Compared to Standard Oxygen Therapy for Endoscopic Ultrasound Procedure in High Risk Patients on Recovery Time and Procedural Conditions","ENROLLING_BY_INVITATION","2026-10","2026-01","2026-01-07","2025-07-14","Mayo Clinic","OTHER",false,"The purpose of the study is to evaluate the use of high flow nasal cannula versus standard oxygen therapy for high-risk patients undergoing endoscopy procedures.","Patients with a higher BMI are at greater risk for lower oxygen levels which can delay the endoscopy procedure. This research is being conducted to find out if high risk patients will have a shorter recovery time and improved procedural conditions with a high flow nasal cannula versus standard oxygen therapy.",[19],"Endoscopic Ultrasound",[21,22,23],"High Flow Nasal Cannula","High BMI","Oxygen","INTERVENTIONAL","SUPPORTIVE_CARE",[27],"NA",{"count":29,"type":30},200,"ESTIMATED",[32],{"type":14,"name":33,"description":34,"armGroupLabels":35},"High flow nasal cannula","Subjects undergoing endoscopic ultrasound will receive high flow nasal cannula during the procedure",[21],[37],{"measure":38,"description":39,"timeFrame":40},"Decrease recovery time","Time measured in minutes for participants to enter post anesthesia care until the nurse marks \"ready for discharge\" in the medical record.","4 hours",[42],{"measure":43,"description":44,"timeFrame":45},"Improve procedural conditions","Decreased number of times the procedure is paused or delayed.","1 hour","ALL","18 Years",null,{"inclusion":50,"exclusion":51,"raw_text":62},[],[52,53,54,55,56,57,58,59,60,61],"Need for general anesthesia for the procedure instead of the standard monitored anesthesia care.","Patients undergoing combined procedure: Therapeutic EUS\u002Fcombined procedures including EUS\u002FERCP, EUS\u002Fcolonoscopy","Patients on home oxygen therapy, or the diagnosis of \"severe COPD\"","Patients with existing tracheostomy","Inpatients undergoing EUS","Inability to consent","Cognitive impairment","Blocked nasal passages","Trauma\u002Fprevious surgery to the nasopharynx","Irregularities of the nose, face, or airway such that HFNC cannot be properly fitted","Inclusion Criteria:\n\n• All patients age 18 years and older who present to Gonda 2 procedural area for Endoscopic ultrasound (EUS) with or without endoscopy (EGD)\u002Fbiopsy\u002Ftissue sampling. with BMI ≥ 35 kg\u002Fm2 (BMI within the past 6 months in electronic medical records or at current procedure) who are able to consent will be approached for potential enrollment.\n\nExclusion Criteria:\n\n* Need for general anesthesia for the procedure instead of the standard monitored anesthesia care.\n* Patients undergoing combined procedure: Therapeutic EUS\u002Fcombined procedures including EUS\u002FERCP, EUS\u002Fcolonoscopy\n* Patients on home oxygen therapy, or the diagnosis of \"severe COPD\"\n* Patients with existing tracheostomy\n* Inpatients undergoing EUS\n* Inability to consent\n* Cognitive impairment\n* Blocked nasal passages\n* Trauma\u002Fprevious surgery to the nasopharynx\n* Irregularities of the nose, face, or airway such that HFNC cannot be properly fitted",[64,65],"ADULT","OLDER_ADULT",[67],{"facility":13,"city":68,"state":69,"zip":70,"country":71,"geoPoint":72},"Rochester","Minnesota","55901","United States",{"lat":73,"lon":74},44.02163,-92.4699,[],[77],{"name":78,"affiliation":13,"role":79},"Bhargavi Gali, MD, MHA","PRINCIPAL_INVESTIGATOR",[],[]]